drugset / Trial / NCT00860743

Respiratory and Autonomic Plasticity Following Intermittent Hypoxia

NCT00860743

Phase 0 Completed 63 enrolled VA Office of Research and Development
RandomizedFactorialDouble-blindBasic science

Summary

The prevalence of obstructive sleep apnea is high in the Veteran population. If not treated promptly, sleep apnea may result in daytime fatigue which may lead to increased prevalence of accidents while driving or in the workplace. Recent large scale epidemiological studies have shown that the prevalence of excessive daytime sleepiness increases in individuals who suffer from obstructive sleep apnea. Obstructive sleep apnea may also result in the development of hypertension and other cardiovascular disorders. Previous findings have shown that subjects with sleep apnea have a greater risk for developing coronary vascular disease compared to individuals that do not suffer from sleep apnea Thus, a significant amount of evidence suggests that sleep apnea is a major health concern in the Veteran population. Consequently, determining the mechanisms that may impact on the severity of sleep apnea and increase the prevalence of cardiovascular incidents associated with this disorder is important, as is discovering novel treatments.

Timeline

Start
2009-09
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 120 mg Oral
Subject ORGOTEIN Protein / enzyme biologic 800 mg Oral
Subject Vitamin C Other / unclassified 1 g Intravenous
Subject Vitamin E Other / unclassified 400 iu Oral

Indications